Logo image of CSAN

COSAN SA -ADR (CSAN) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:CSAN - US22113B1035 - ADR

4.19 USD
-0.14 (-3.23%)
Last: 12/17/2025, 8:11:05 PM
4.2 USD
+0.01 (+0.24%)
After Hours: 12/17/2025, 8:11:05 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CSAN. CSAN was compared to 122 industry peers in the Specialty Retail industry. While CSAN is still in line with the averages on profitability rating, there are concerns on its financial health. CSAN has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CSAN had negative earnings in the past year.
In the past year CSAN had a positive cash flow from operations.
Of the past 5 years CSAN 4 years were profitable.
In the past 5 years CSAN always reported a positive cash flow from operatings.
CSAN Yearly Net Income VS EBIT VS OCF VS FCFCSAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B 10B

1.2 Ratios

With a Return On Assets value of -9.31%, CSAN is not doing good in the industry: 73.77% of the companies in the same industry are doing better.
CSAN's Return On Equity of -163.24% is on the low side compared to the rest of the industry. CSAN is outperformed by 76.23% of its industry peers.
The Return On Invested Capital of CSAN (6.48%) is better than 62.30% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CSAN is significantly below the industry average of 12.16%.
The last Return On Invested Capital (6.48%) for CSAN is above the 3 year average (4.36%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -9.31%
ROE -163.24%
ROIC 6.48%
ROA(3y)-1.67%
ROA(5y)0.73%
ROE(3y)-25.17%
ROE(5y)-5.22%
ROIC(3y)4.36%
ROIC(5y)4.21%
CSAN Yearly ROA, ROE, ROICCSAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60 -80

1.3 Margins

With an excellent Operating Margin value of 20.98%, CSAN belongs to the best of the industry, outperforming 98.36% of the companies in the same industry.
In the last couple of years the Operating Margin of CSAN has declined.
With a Gross Margin value of 31.48%, CSAN is not doing good in the industry: 62.30% of the companies in the same industry are doing better.
CSAN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 20.98%
PM (TTM) N/A
GM 31.48%
OM growth 3Y3.25%
OM growth 5Y-3.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.35%
GM growth 5Y1.27%
CSAN Yearly Profit, Operating, Gross MarginsCSAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CSAN is destroying value.
Compared to 1 year ago, CSAN has less shares outstanding
The number of shares outstanding for CSAN has been increased compared to 5 years ago.
CSAN has a worse debt/assets ratio than last year.
CSAN Yearly Shares OutstandingCSAN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B
CSAN Yearly Total Debt VS Total AssetsCSAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B

2.2 Solvency

Based on the Altman-Z score of 0.84, we must say that CSAN is in the distress zone and has some risk of bankruptcy.
CSAN's Altman-Z score of 0.84 is on the low side compared to the rest of the industry. CSAN is outperformed by 72.95% of its industry peers.
The Debt to FCF ratio of CSAN is 17.68, which is on the high side as it means it would take CSAN, 17.68 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CSAN (17.68) is comparable to the rest of the industry.
CSAN has a Debt/Equity ratio of 8.61. This is a high value indicating a heavy dependency on external financing.
CSAN has a Debt to Equity ratio of 8.61. This is amonst the worse of the industry: CSAN underperforms 81.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 8.61
Debt/FCF 17.68
Altman-Z 0.84
ROIC/WACC0.84
WACC7.68%
CSAN Yearly LT Debt VS Equity VS FCFCSAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.3 Liquidity

A Current Ratio of 1.83 indicates that CSAN should not have too much problems paying its short term obligations.
CSAN has a Current ratio of 1.83. This is amongst the best in the industry. CSAN outperforms 80.33% of its industry peers.
A Quick Ratio of 1.68 indicates that CSAN should not have too much problems paying its short term obligations.
With an excellent Quick ratio value of 1.68, CSAN belongs to the best of the industry, outperforming 86.89% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.83
Quick Ratio 1.68
CSAN Yearly Current Assets VS Current LiabilitesCSAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

5

3. Growth

3.1 Past

CSAN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -872.35%.
The Revenue has grown by 11.36% in the past year. This is quite good.
CSAN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 26.51% yearly.
EPS 1Y (TTM)-872.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-526.67%
Revenue 1Y (TTM)11.36%
Revenue growth 3Y20.84%
Revenue growth 5Y26.51%
Sales Q2Q%-8.43%

3.2 Future

CSAN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 36.03% yearly.
CSAN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.59% yearly.
EPS Next Y73.79%
EPS Next 2Y53.09%
EPS Next 3Y36.03%
EPS Next 5YN/A
Revenue Next Year-3.12%
Revenue Next 2Y-1.25%
Revenue Next 3Y0.37%
Revenue Next 5Y2.59%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CSAN Yearly Revenue VS EstimatesCSAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50B 100B 150B
CSAN Yearly EPS VS EstimatesCSAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4

5

4. Valuation

4.1 Price/Earnings Ratio

CSAN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 14.46, the valuation of CSAN can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CSAN indicates a somewhat cheap valuation: CSAN is cheaper than 69.67% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of CSAN to the average of the S&P500 Index (23.58), we can say CSAN is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 14.46
CSAN Price Earnings VS Forward Price EarningsCSAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CSAN is valued a bit cheaper than the industry average as 75.41% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, CSAN is valued cheaper than 87.70% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.7
EV/EBITDA 6.22
CSAN Per share dataCSAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

CSAN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CSAN's earnings are expected to grow with 36.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y53.09%
EPS Next 3Y36.03%

5

5. Dividend

5.1 Amount

CSAN has a Yearly Dividend Yield of 2.44%.
The stock price of CSAN dropped by -25.97% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
CSAN's Dividend Yield is rather good when compared to the industry average which is at 1.84. CSAN pays more dividend than 85.25% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 1.87, CSAN pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.44%

5.2 History

The dividend of CSAN is nicely growing with an annual growth rate of 25.09%!
CSAN has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)25.09%
Div Incr Years0
Div Non Decr Years0
CSAN Yearly Dividends per shareCSAN Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 0.5 1

5.3 Sustainability

The earnings of CSAN are negative and hence is the payout ratio. CSAN will probably not be able to sustain this dividend level.
The dividend of CSAN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-25.08%
EPS Next 2Y53.09%
EPS Next 3Y36.03%
CSAN Yearly Income VS Free CF VS DividendCSAN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B

COSAN SA -ADR

NYSE:CSAN (12/17/2025, 8:11:05 PM)

After market: 4.2 +0.01 (+0.24%)

4.19

-0.14 (-3.23%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-14 2025-11-14/amc
Earnings (Next)02-24 2026-02-24/amc
Inst Owners10.43%
Inst Owner Change2.52%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap6.05B
Revenue(TTM)43.95B
Net Income(TTM)-11.74B
Analysts78.82
Price Target6.07 (44.87%)
Short Float %0.93%
Short Ratio5.25
Dividend
Industry RankSector Rank
Dividend Yield 2.44%
Yearly Dividend0.44
Dividend Growth(5Y)25.09%
DP-25.08%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-812.09%
Min EPS beat(2)-1027.4%
Max EPS beat(2)-596.78%
EPS beat(4)0
Avg EPS beat(4)-744.76%
Min EPS beat(4)-1285.85%
Max EPS beat(4)-69.01%
EPS beat(8)1
Avg EPS beat(8)-367.61%
EPS beat(12)2
Avg EPS beat(12)-257.65%
EPS beat(16)4
Avg EPS beat(16)-198.12%
Revenue beat(2)0
Avg Revenue beat(2)-75.19%
Min Revenue beat(2)-76.92%
Max Revenue beat(2)-73.47%
Revenue beat(4)0
Avg Revenue beat(4)-74.24%
Min Revenue beat(4)-76.92%
Max Revenue beat(4)-72.24%
Revenue beat(8)0
Avg Revenue beat(8)-55.64%
Revenue beat(12)0
Avg Revenue beat(12)-51.45%
Revenue beat(16)0
Avg Revenue beat(16)-57.72%
PT rev (1m)10.1%
PT rev (3m)-6.57%
EPS NQ rev (1m)-36.38%
EPS NQ rev (3m)-70.56%
EPS NY rev (1m)36.38%
EPS NY rev (3m)-23.56%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.34%
Revenue NY rev (3m)0.76%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 14.46
P/S 0.75
P/FCF 8.7
P/OCF 2.6
P/B 4.57
P/tB N/A
EV/EBITDA 6.22
EPS(TTM)-1.31
EYN/A
EPS(NY)0.29
Fwd EY6.92%
FCF(TTM)0.48
FCFY11.5%
OCF(TTM)1.61
OCFY38.45%
SpS5.56
BVpS0.92
TBVpS-2.46
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.31%
ROE -163.24%
ROCE 8.21%
ROIC 6.48%
ROICexc 7.59%
ROICexgc 10.52%
OM 20.98%
PM (TTM) N/A
GM 31.48%
FCFM 8.67%
ROA(3y)-1.67%
ROA(5y)0.73%
ROE(3y)-25.17%
ROE(5y)-5.22%
ROIC(3y)4.36%
ROIC(5y)4.21%
ROICexc(3y)5.12%
ROICexc(5y)5.21%
ROICexgc(3y)6.64%
ROICexgc(5y)7.56%
ROCE(3y)5.52%
ROCE(5y)5.33%
ROICexgc growth 3Y5.58%
ROICexgc growth 5Y-20.62%
ROICexc growth 3Y6.6%
ROICexc growth 5Y-13.61%
OM growth 3Y3.25%
OM growth 5Y-3.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.35%
GM growth 5Y1.27%
F-Score6
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 8.61
Debt/FCF 17.68
Debt/EBITDA 4.71
Cap/Depr 221.51%
Cap/Sales 20.32%
Interest Coverage 1.74
Cash Conversion 96.15%
Profit Quality N/A
Current Ratio 1.83
Quick Ratio 1.68
Altman-Z 0.84
F-Score6
WACC7.68%
ROIC/WACC0.84
Cap/Depr(3y)179.81%
Cap/Depr(5y)178.28%
Cap/Sales(3y)15.09%
Cap/Sales(5y)13.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-872.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-526.67%
EPS Next Y73.79%
EPS Next 2Y53.09%
EPS Next 3Y36.03%
EPS Next 5YN/A
Revenue 1Y (TTM)11.36%
Revenue growth 3Y20.84%
Revenue growth 5Y26.51%
Sales Q2Q%-8.43%
Revenue Next Year-3.12%
Revenue Next 2Y-1.25%
Revenue Next 3Y0.37%
Revenue Next 5Y2.59%
EBIT growth 1Y48.56%
EBIT growth 3Y24.77%
EBIT growth 5Y21.84%
EBIT Next Year102.33%
EBIT Next 3Y32.61%
EBIT Next 5Y17.37%
FCF growth 1Y-35.46%
FCF growth 3Y65.47%
FCF growth 5Y21.36%
OCF growth 1Y14.86%
OCF growth 3Y35.81%
OCF growth 5Y36.03%

COSAN SA -ADR / CSAN FAQ

What is the ChartMill fundamental rating of COSAN SA -ADR (CSAN) stock?

ChartMill assigns a fundamental rating of 4 / 10 to CSAN.


What is the valuation status of COSAN SA -ADR (CSAN) stock?

ChartMill assigns a valuation rating of 5 / 10 to COSAN SA -ADR (CSAN). This can be considered as Fairly Valued.


Can you provide the profitability details for COSAN SA -ADR?

COSAN SA -ADR (CSAN) has a profitability rating of 4 / 10.


Can you provide the expected EPS growth for CSAN stock?

The Earnings per Share (EPS) of COSAN SA -ADR (CSAN) is expected to grow by 73.79% in the next year.